Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Novartis AG (NVS)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 15,247 | 0.03 | Add 37.70% | <0.01 | $152.75 | $2,328,979 | SEC |
| 2025 Q4 | 11,073 | 0.02 | Add 34.68% | <0.01 | $137.87 | $1,526,635 | SEC |
| 2025 Q3 | 8,222 | 0.01 | Buy | 0.01 | $128.24 | $1,054,389 | SEC |
| 2024 Q3 | 0 | 0.00 | Sell 100.00% | 0.03 | SEC | ||
| 2024 Q2 | 17,038 | 0.03 | Add 297.06% | 0.02 | $106.46 | $1,813,865 | SEC |
| 2024 Q1 | 4,291 | 0.01 | Buy | 0.01 | $96.73 | $415,068 | SEC |
| 2021 Q2 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2021 Q1 | 1,987 | <0.01 | Buy | <0.01 | $85.56 | $170,000 | SEC |
| 2020 Q2 | 0 | 0.00 | Sell 100.00% | 0.03 | SEC | ||
| 2020 Q1 | 18,918 | 0.03 | Buy | 0.03 | $82.46 | $1,560,000 | SEC |
| 2015 Q1 | 0 | 0.00 | Sell 100.00% | 0.84 | SEC | ||
| 2014 Q4 | 519,369 | 0.84 | Add 90.55% | 0.40 | $92.66 | $48,125,000 | SEC |
| 2014 Q3 | 272,570 | 0.43 | Buy | 0.43 | $94.13 | $25,657,000 | SEC |
| 2014 Q2 | 0 | 0.00 | Sell 100.00% | 0.44 | SEC | ||
| 2014 Q1 | 351,580 | 0.44 | Add 31.52% | 0.11 | $85.02 | $29,891,000 | SEC |
| 2013 Q4 | 267,321 | 0.29 | Reduce 66.76% | 0.57 | $80.38 | $21,487,000 | SEC |
| 2013 Q3 | 804,099 | 0.86 | Add 8.41% | 0.07 | $76.71 | $61,682,000 | SEC |
| 2013 Q2 | 741,689 | 0.72 | Add 39.50% | 0.20 | $70.71 | $52,445,000 | SEC |
| 2013 Q1 | 531,689 | 0.50 | Buy | 0.50 | $71.24 | $37,878,000 | SEC |